Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a deployment update. This appears to be a deployment-level metadata change with no modification to the study details or visible content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedNew update dates (2026-07-02, 2026-07-01, 2026-06) were added to the study's record history, and older dates (2026-06-24, 2026-06-23, 2026-02) were removed. This describes changes to the record's revision timeline and update history.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page now includes the Arm I dosing schedule and treatment duration, MRI/blood collection procedures, and lists a participating site, plus the addition of MTD/RP2D and EFS endpoints, quality-of-life measures, and other trial details.SummaryDifference0.3%

- Check40 days agoChange DetectedAdded recruitment status notice 'No longer looking for participants' and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a page revision indicator 'Revision: v3.6.0'. Adjusted the heading from 'Intervention / Treatment' to 'Intervention/Treatment' and removed the older revision tag 'Revision: v3.5.5'.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision from v3.5.4 to v3.5.5 indicates a minor metadata update to the page, with no apparent changes to study details.SummaryDifference0.0%

- Check68 days agoChange DetectedA new 'Sample Collection' entry was added on 2026-05-13, and the study documentation was updated to Revision: v3.5.4 on 2026-05-12, replacing Revision: v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.